Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

Jazz Pharmaceuticals’ GW Pharmaceuticals Received UK Approval for EPIDYOLEX for the Treatment of Seizures Associated with Tuberous Sclerosis Complex

GW Pharmaceuticals ("GW"), a world leader in discovering, developing and delivering regulatory approved cannabis-based medicines and now part of Jazz Pharmaceuticals plc (NASDAQ: JAZZ), today announces that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved a new indication for GW's cannabidiol as a

JAZZ